The prevalence of diabetes in India, especially diabetes 2, has been rising every year. It occurs due to the destruction of insulin-producing beta islet cells in the pancreas by the immune system. Insulin stimulates the absorption of blood glucose by cells and reduced insulin results in increased blood glucose levels. The elevated blood glucose levels leads to other disorders such as, cardiovascular diseases, eye disorders, kidney damage, etc.
The current medications include insulin injections, glucose-lowering drugs, and lifestyle changes. A diabetic person develops a lifelong dependency on these drugs with no absolute cure in sight.
However, the tissue regenerative potential of stem cell therapy can be applied for diabetes treatment. The mesenchymal stem cells differentiate into the tissue cells, reduce inflammation, and promote cell expansion. Their administration has the ability to restore the beta islet cells and the subsequent insulin production.
Advancells is the leading manufacturer of mesenchymal stem cells extracted from human umbilical cord blood in India.
Contact our team at +91-9654321400 to learn more about the stem cells and their applications in diabetes.
Learn more: https://www.advancells.com/ste....m-cell-treatment-dia
